Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer

Nature Genetics

Volumn 48, Issue 5, 2016, Pages 500-509

  Fujimoto, Akihiro ^a   Furuta, Mayuko ^a   Totoki, Yasushi ^b   Tsunoda, Tatsuhiko ^a,c,d   Kato, Mamoru ^b,d   Shiraishi, Yuichi ^e   Tanaka, Hiroko ^e   Taniguchi, Hiroaki ^a   Kawakami, Yoshiiku ^f   Ueno, Masaki ^g   Gotoh, Kunihito ^h   Ariizumi, Shun Ichi ⁱ   Wardell, Christopher P ^a   Hayami, Shinya ^g   Nakamura, Toru ^j   Aikata, Hiroshi ^f   Arihiro, Koji ^f   Boroevich, Keith A ^a   Abe, Tetsuo ^a   Nakano, Kaoru ^a   Maejima, Kazuhiro ^a   Sasaki Oku, Aya ^a   Ohsawa, Ayako ^a   Shibuya, Tetsuo ^e   Nakamura, Hiromi ^b   Hama, Natsuko ^b   Hosoda, Fumie ^b   Arai, Yasuhito ^b   Ohashi, Shoko ^b   Urushidate, Tomoko ^e   Nagae, Genta ^k   Yamamoto, Shogo ^k   Ueda, Hiroki ^k   Tatsuno, Kenji ^k   Ojima, Hidenori ^l   Hiraoka, Nobuyoshi ^m   Okusaka, Takuji ^m   Kubo, Michiaki ^a   Marubashi, Shigeru ^h   Yamada, Terumasa ^h   Hirano, Satoshi ^j   Yamamoto, Masakazu ⁱ   Ohdan, Hideki ^f   Shimada, Kazuaki ^m   Ishikawa, Osamu ^h   Yamaue, Hiroki ^g   Chayama, Kazuki ^a,f   Miyano, Satoru ^e   Aburatani, Hiroyuki ^k   Shibata, Tatsuhiro ^b,e   Nakagawa, Hidewaki ^a   more..

^a Institute of Physical and Chemical Research   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^g WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^h OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

ⁱ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^j HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k UNIVERSITY OF TOKYO   (Japan)

^l KEIO UNIVERSITY   (Japan)

^m NATIONAL CANCER CENTER HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; ASH1L PROTEIN; CCND1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MACROD2 PROTEIN; MALAT1 PROTEIN; NCOR1 PROTEIN; NEAT1 PROTEIN; PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR CTCF; UNCLASSIFIED DRUG; DNA; TUMOR PROTEIN;

ARTICLE; BINDING SITE; CANCER PROGNOSIS; CHROMOSOME 17; CONTROLLED STUDY; DNA REPLICATION TIMING; DOUBLE STRANDED DNA BREAK; ENHANCER REGION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; INDEL MUTATION; INTRON; JAPANESE (PEOPLE); LIVER CANCER; LIVER CARCINOGENESIS; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MICROORGANISM DETECTION; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SOMATIC MUTATION; VIRUS DNA CELL DNA INTERACTION; WHOLE GENOME SEQUENCING; DNA MUTATIONAL ANALYSIS; DNA SEQUENCE; GENETICS; HUMAN GENOME; LIVER TUMOR; MUTATION; PROGNOSIS; REGULATORY SEQUENCE;

DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENETIC STRUCTURES; GENOME, HUMAN; HUMANS; LIVER NEOPLASMS; MUTATION; NEOPLASM PROTEINS; PROGNOSIS; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA; VIRUS INTEGRATION;

EID: 84963588792     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3547     Document Type: Article

References (63)

1. El-Serag H.B, & Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 132, 2557-2576 (2007).
2. Li M, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat. Genet. 43, 828-829 (2011).
3. Totoki Y, et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat. Genet. 43, 464-469 (2011).
4. Fujimoto A, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet. 44, 760-764 (2012).
5. Guichard C, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet. 44, 694-698 (2012).
6. Kan Z, et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res. 23, 1422-1433 (2013).
7. Totoki Y, et al. Trans-Ancestry mutational landscape of hepatocellular carcinoma genomes. Nat. Genet. 46, 1267-1273 (2014).
8. Huang J, et al. Exome sequencing of hepatitis B virus-Associated hepatocellular carcinoma. Nat. Genet. 44, 1117-1121 (2012).
9. Sung W.K, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 44, 765-769 (2012).
10. Jiang Z, et al. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res. 22, 593-601 (2012).
11. Jhunjhunwala S, et al. Diverse modes of genomic alteration in hepatocellular carcinoma. Genome Biol. 15, 436 (2014).
12. Schulze K, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47, 505-511 (2015).
13. Weinhold N, Jacobsen A, Schultz N, Sander C, & Lee W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat. Genet. 46, 1160-1165 (2014).
14. Nault J.C, et al. High frequency of telomerase reverse-Transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat. Commun. 4, 2218 (2013).
15. George J, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 524, 47-53 (2015).
16. Waddell N, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 518, 495-501 (2015).
17. Northcott P.A, et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature. 511, 428-434 (2014).
18. Stephens P.J, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 144, 27-40 (2011).
19. Fujimoto A, et al. Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. Nat. Commun. 6, 6120 (2015).
20. Tomasetti C, Vogelstein B, & Parmigiani G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc. Natl. Acad. Sci. USA. 110, 1999-2004 (2013).
21. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 489, 57-74 (2012).
22. Woo Y.H, & Li W.H. DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes. Nat. Commun. 3, 1004 (2012).
23. Polak P, et al. Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature. 518, 360-364 (2015).
24. Alexandrov L.B, et al. Signatures of mutational processes in human cancer. Nature. 500, 415-421 (2013).
25. Miyakawa Y, & Mizokami M. Classifying hepatitis B virus genotypes. Intervirology. 46, 329-338 (2003).
26. Bill C.A, & Summers J. Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc. Natl. Acad. Sci. USA. 101, 11135-11140 (2004).
27. Nault J.C, et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat. Genet. 47, 1187-1193 (2015).
28. Ceol C.J, et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature. 471, 513-517 (2011).
29. Liu Q, et al. Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism. Proc. Natl. Acad. Sci. USA. 109, 14568-14573 (2012).
30. Si-Tayeb K, Lemaigre F.P, & Duncan S.A. Organogenesis and development of the liver. Dev. Cell. 18, 175-189 (2010).
31. Harrow J, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760-1774 (2012).
32. Walker S.R, et al. STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. Mol. Cell. Biol. 33, 2879-2890 (2013).
33. Wong C.M, et al. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology. 45, 1129-1138 (2007).
34. Xu C, et al. Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer. BMC Cancer. 13, 118 (2013).
35. Hirose T, et al. NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies. Mol. Biol. Cell. 25, 169-183 (2014).
36. Li Y, et al. NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget. 6, 27641-27650 (2015).
37. Jopling C.L, Yi M, Lancaster A.M, Lemon S.M, & Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science. 309, 1577-1581 (2005).
38. Tsai W.C, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 49, 1571-1582 (2009).
39. Heidari N, et al. Genome-wide map of regulatory interactions in the human genome. Genome Res. 24, 1905-1917 (2014).
40. De S, & Michor F. DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes. Nat. Biotechnol. 29, 1103-1108 (2011).
41. Nik-Zainal S, et al. Mutational processes molding the genomes of 21 breast cancers. Cell. 149, 979-993 (2012).
42. Ni S, et al. Down expression of LRP1B promotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer. Cancer Sci. 104, 817-825 (2013).
43. Pitkänen E, et al. Frequent L1 retrotranspositions originating from TTC28 in colorectal cancer. Oncotarget. 5, 853-859 (2014).
44. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 487, 330-337 (2012).
45. Bignell G.R, et al. Signatures of mutation and selection in the cancer genome. Nature. 463, 893-898 (2010).
46. Jankevicius G, et al. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation. Nat. Struct. Mol. Biol. 20, 508-514 (2013).
47. Yoon H.G, et al. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22, 1336-1346 (2003).
48. Weischenfeldt J, Symmons O, Spitz F, & Korbel J.O. Phenotypic impact of genomic structural variation: insights from and for human disease. Nat. Rev. Genet. 14, 125-138 (2013).
49. Kaneda A, et al. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res. 64, 6410-6415 (2004).
50. Hofree M, Shen J.P, Carter H, Gross A, & Ideker T. Network-based stratification of tumor mutations. Nat. Methods. 10, 1108-1115 (2013).
51. Song S, Wheeler L.J, & Mathews C.K. Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J. Biol. Chem. 278, 43893-43896 (2003).
52. Guo T, Chen T, Gu C, Li B, & Xu C. Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer. Tumour Biol. 36, 7649-7658 (2015).
53. Chakravarty D, et al. The oestrogen receptor a-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat. Commun. 5, 5383 (2014).
54. Choudhry H, et al. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2a dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene. 34, 4482-4490 (2015).
55. Kawaguchi T, et al. SWI/SNF chromatin-remodeling complexes function in noncoding RNA-dependent assembly of nuclear bodies. Proc. Natl. Acad. Sci. USA. 112, 4304-4309 (2015).
56. International Cancer Genome Consortium. International network of cancer genome projects. Nature. 464, 993-998 (2010).
57. Ha G, et al. Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer. Genome Res. 22, 1995-2007 (2012).
58. Shiraishi Y, et al. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers. PLoS One 9, e114263 (2014).
59. Benjamini Y, & Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B. 57, 289-300 (1995).
60. Huang W, Sherman B.T, & Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
61. Robinson M.D, McCarthy D.J, & Smyth G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26, 139-140 (2010).
62. Alexandrov L.B, Nik-Zainal S, Wedge D.C, Campbell P.J, & Stratton M.R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246-259 (2013).
63. Vanunu O, Magger O, Ruppin E, Shlomi T, & Sharan R. Associating genes and protein complexes with disease via network propagation. PLoS Comput. Biol. 6, e1000641 (2010).